Treating asthma has been the same way for the past 50 years and new drugs are urgently needed to treat this chronic respiratory disease. Nearly 25 million people in the United States alone to wheeze, cough, and find it difficult at best to take a deep breath.
But finding new treatments is tough: asthma is a patient-specific disease, so what works for one person doesn't necessarily work for another, and the animal models traditionally used to test new drug candidates often fail to mimic human responses - costing tremendous money and time.
AdvertisementHope for healthier airways may be on the horizon thanks to a Harvard University team that has developed a human airway muscle-on-a-chip that could be used to test new drugs because it accurately mimics the way smooth muscle contracts in the human airway, under normal circumstances and when exposed to asthma triggers. As reported in the journal Lab on a Chip, it also offers a window into the cellular and even subcellular responses within the tissue during an asthmatic event.
"Every year asthma costs many tens of billions of dollars, significant productivity due to lost work and school days, and even lives," said senior author Kevin Kit Parker, Ph.D., a Core Faculty member at Harvard's Wyss Institute for Biologically Inspired Engineering and Tarr Family Professor of Bioengineering and Applied Physics at the Harvard School of Engineering and Applied Sciences (SEAS). Parker leads development of the Wyss Institute's heart-on-a-chip technology as well and is specifically interested in diseases that affect children. "We were thrilled with how well the chip recapitulated the functioning of the human airway."
The chip, a soft polymer well that is mounted on a glass substrate, contains a planar array of microscale, engineered human airway muscles, designed to mimic the laminar structure of the muscular layers of the human airway.
To mimic a typical allergic asthma response, the team first introduced interleukin-13 (IL-13) to the chip. IL-13 is a natural protein often found in the airway of asthmatic patients that mediates the response of smooth muscle to an allergen.
Then they introduced acetylcholine, a neurotransmitter that causes smooth muscle to contract. Sure enough, the airway muscle on the chip hypercontracted - and the soft chip curled up - in response to higher doses of the neurotransmitter.
P Mad Men Skirts and Beehive Hair At Paris Fashion Week Babbling And Cooing In Infants Connected To Hearing Ability M
You May Also Like